Von Willebrand factor in type 1 diabetes: Its relationship with endothelial nitric oxide production and coronary artery calcification

Medical Science Monitor

Volumn 9, Issue 7, 2003, Pages

  Chan, Norman N ^b   Fuller, John Harry ^c   Rubens, Michael ^a   Colhoun, Helen Martina ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NONE

Author keywords

Coronary calcification; Diabetes; Nitric oxide; Von Willebrand factor

Indexed keywords

BRADYKININ; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; NORADRENALIN; VON WILLEBRAND FACTOR;

ADULT; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ELECTRON BEAM TOMOGRAPHY; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PLETHYSMOGRAPHY; PROTEINURIA;

ADULT; ALBUMINURIA; AREA UNDER CURVE; BRADYKININ; CALCINOSIS; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; NITRIC OXIDE; NITROGLYCERIN; OMEGA-N-METHYLARGININE; RISK FACTORS; STATISTICS; VASODILATOR AGENTS; VON WILLEBRAND FACTOR;

EID: 17444441200     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wagner DD, Marder VJ: Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. J Biol Chem, 1983; 258: 2065-2067
2. Ruggeri ZM, Ware J: The structure and function of von Willebrand factor. Thromb Haemost, 1992; 67: 594-599
3. Mannucci PM: Von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol, 1998; 18: 1359-1362
4. Thompson SG, Kienast J, Pyke SD et al: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med, 1995; 332: 635-641
5. Jansson JH, Nilsson TK, Johnson O: Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J, 1991; 66: 351-355
6. Jager A, van Hinsbergh VW, Kostense PJ et al: Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol, 1999; 19: 3071-307
7. Corda R, Alberti M, Caocci L et al: An increased factor VIII antigen as an indicator of endothelial damage in measles. Thromb Res, 1979; 14: 805-810
8. Greaves M, Malia RG, Goodfellow K, the EURODIAB IDDM Complications Study Group et al: Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study. Diabetologia, 1997; 40: 698-705
9. Jensen T: Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. Br Med J, 1989; 298: 27-28
10. Stehouwer CD, Stroes ES, Hackeng WH et al: Von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes, 1991; 40: 971-976
11. Stehouwer CD, Fischer HR, van Kuijk AW et al: Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes, 1995; 44: 561-564
12. Jensen T, Bjerre Knudsen J, Feldt Rasmussen B, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet, 1989; 1: 461-463
13. Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest, 1992; 90: 2548-2554
14. Elliott TG, Cockcroft JR, Groop PH et al: Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci, 1993; 85: 687-693
15. Huvers FC, De Leeuw PW, Houben AJ et al: Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes, 1999; 48: 1300-1307
16. Chan NN, Vallance P, Colhoun HM: Nitric oxide and vascular responses in Type 1 diabetes. Diabetologia, 2000; 43: 137-147
17. Rumberger JA, Simons DB, Fitzpatrick LA et al: Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation, 1995; 92: 2157-2162
18. Colhoun HM, Rubens MB, Underwood SR, Fuller JH: The effect of Type 1 Diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol, 2001; 36: 2160-2167
19. Allain CC, Poon LS, Chan CS et al: Enzymatic determination of total serum cholesterol. Clin Chem, 1974; 20: 470-475
20. Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem, 1982; 28: 2077-2080
21. Sugiuchi H, Uji Y, Okabe H et al: Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem, 1995; 41: 717-723
22. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
23. Jager A, Kostense PJ, Ruhe HG et al: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol, 1999; 19: 617-624
24. Agatston AS, Janowitz WR, Hildner FJ et al: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol, 1990; 15: 827-832
25. Nikkila EA: High density lipoproteins in diabetes. Diabetes, 1981; 30: 82-87
26. Bensoussan D, Levy TS, Passa P, et al: Platelet hyperaggregation and increased plasma level of Von Willebrand factor in diabetics with retinopathy. Diabetologia, 1975; 11: 307-312
27. Stehouwer CD, Zellenrath P, Polak BC et al: Von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia, 1992; 35: 555-559
28. Yaqoob M, Patrick AW, McClelland P et al: Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci, 1993; 85: 557-562
29. Stehouwer CD, Nautaj J, Zeldenrust GC et al: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet, 1992; 340: 319-323
30. Clausen P, Feldt-Rasmussen B, Jensen G, Jensen JS: Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci, 1999; 97: 37-43
31. Stehouwer CD, Gall MA, Twisk JW et al: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes, 2002; 51: 1157-1165
32. Lip GY, Blann AD: 1995 von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J, 1995; 74: 580-583
33. Vallance P, Chan N: Endothelial function and nitric oxide: clinical relevance. Heart, 2001; 85: 342-350
34. McAllister AS, Atkinson AB, Johnston GD, McCance DR: Relationship of endothelial function to birth weight in humans. Diab Care, 1991; 22: 2061-2066
35. Blankenhorn DH: Coronary Arterial Calcification - a review. Am J Med Sci, 1961; 41-50
36. Breen JF, Sheedy PF, Schwartz RS et al: Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology, 1992; 185: 435-439
37. Ridker PM, Hennekens CH, Buring JE et al: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000; 342: 836-843
38. Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CD: C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diab Care, 2002; 25: 1813-1817
39. Park R, Detrano R, Xiang M et al: Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in non-diabetic individuals. Circulation, 2002; 106: 2073-2077